Scienture Holdings, Inc. (NASDAQ:SCNX) Short Interest Update

Scienture Holdings, Inc. (NASDAQ:SCNX) was the recipient of a large increase in short interest in the month of September. As of September 15th, there was short interest totaling 212,600 shares, an increase of 64.0% from the August 31st total of 129,600 shares. Based on an average daily volume of 354,600 shares, the short-interest ratio is presently 0.6 days. Currently, 1.4% of the company’s shares are short sold. Currently, 1.4% of the company’s shares are short sold. Based on an average daily volume of 354,600 shares, the short-interest ratio is presently 0.6 days.

Hedge Funds Weigh In On Scienture

An institutional investor recently bought a new position in Scienture stock. Millennium Management LLC acquired a new stake in Scienture Holdings, Inc. (NASDAQ:SCNX) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 33,987 shares of the company’s stock, valued at approximately $206,000. Millennium Management LLC owned about 0.39% of Scienture at the end of the most recent reporting period. 5.68% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SCNX has been the subject of a number of research analyst reports. Wall Street Zen lowered shares of Scienture from a “hold” rating to a “sell” rating in a report on Sunday, August 17th. Weiss Ratings reiterated a “sell (d)” rating on shares of Scienture in a research note on Saturday, September 27th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

Scienture Trading Down 7.5%

Shares of SCNX opened at $0.78 on Wednesday. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.11 and a quick ratio of 0.11. Scienture has a 12-month low of $0.69 and a 12-month high of $9.55. The firm has a 50-day moving average price of $1.20 and a 200 day moving average price of $1.19.

Scienture (NASDAQ:SCNX) last announced its earnings results on Tuesday, August 12th. The company reported ($0.48) earnings per share for the quarter. Scienture had a negative return on equity of 24.47% and a negative net margin of 10,364.22%.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.